Ess, S M <br/><br/>
Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.  [electronic resource] 

 -  European journal of cancer care  Nov 2017 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2354 
<br/><br/><label>Standard No.: </label>10.1111/ecc.12721  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--genetics<br/>Age Factors<br/>Aged<br/>Anaplastic Lymphoma Kinase<br/>Carcinoma, Large Cell--genetics<br/>Carcinoma, Non-Small-Cell Lung--genetics<br/>Cohort Studies<br/>ErbB Receptors--genetics<br/>Female<br/>Genetic Testing--statistics & numerical data<br/>Humans<br/>Lung Neoplasms--genetics<br/>Male<br/>Middle Aged<br/>Mutation<br/>Neoplasm Metastasis<br/>Receptor Protein-Tyrosine Kinases--genetics<br/>Survival Rate<br/>Switzerland